International Journal of Thyroidology

Indexed in /covered by CAS, KoreaScience & DOI/Crossref:eISSN 2466-1899   pISSN 2384-3799

Table. 4.

Table. 4.

Comparison of the clinicopathologic characteristics between preoperative serum CEA-positive (>5 ng/mL) and CEA-negative patients

CEA-positive patients
n=51
CEA-negative patients
n=43
p
Serum CEA
Median (IQR) 21.5 (11.6-47.3) 2.3 (1.2-3.6) <0.001
Age, years (mean±SD) 53.22±16.12 49.42±12.56 0.206
Sex, female (%) 31 (60.8%) 25 (58.1%) 1.000
Multifocality 12 (23.5%) 7 (16.3%) 0.470
Size, cm (mean±SD) 2.41±1.48 1.13±1.14 <0.001
Gross ETE, present (%) 13 (25.5%) 1 (2.3%) 0.004
N stage <0.001
0 15 30
1a 7 9
1b 29 4
Metastatic LN, number
Median (IQR) 7 (0-11) 0 (0-1) 0.003
Clinical outcome, number (%) 0.026
No evidence of structural disease 42 (82.4) 41 (95.3)
Structural recurrence 8 (15.7) 0 (0)
Death 1 (1.9) 2 (4.7)

CEA: carcinoembryonic antigen, ETE: extrathyroidal extension, IQR: interquartile range, LN: lymph node, SD: standard deviation

Int J Thyroidol 2021;14:143-51 https://doi.org/10.11106/ijt.2021.14.2.143
© 2021 Int J Thyroidol